- Lobbying
- Lobbying by International Contrast Ultrasound Society
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jenifer Healy | Professional Staff, Senate Foreign Relations; Health Counsel, Sen. Bob Corker; LA, Sen. Kay Bailey Hutchinson; Health Policy Advisor, Rep. Sam Johnson; LA, Rep. Phil Gingrey; LC, Rep. Mark Green |
Mark Weller | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Registration
Issue(s) they said they’d lobby about: Regulatory issues surrounding use of contrast enhanced ultrasound technology, comparative effectiveness studies, implementation of the American Reinvestment and Recovery Act of 2009 (ARRA.
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Medicare and Medicaid Services (CMS)
Agency for Health Care Policy & Research
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate